Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Breast Neoplasms 133Neoplasms 114Prostatic Neoplasms 63Lung Neoplasms 47Head and Neck Neoplasms 46Colorectal Neoplasms 35Ovarian Neoplasms 33Uterine Cervical Neoplasms 28Endometrial Neoplasms 23Motor Activity 22Neoplasm Metastasis 20Multiple Myeloma 19Brain Neoplasms 19Pancreatic Neoplasms 18Rectal Neoplasms 17Lymphoma 16Fatigue 16Carcinoma, Non-Small-Cell Lung 16Pain 15Gastrointestinal Neoplasms 15Colonic Neoplasms 15Leukemia 14Depression 14Oropharyngeal Neoplasms 13Urinary Bladder Neoplasms 12Melanoma 12Hematologic Neoplasms 12Esophageal Neoplasms 12Anxiety Disorders 12Stomach Neoplasms 11

Interventions

fludarabine phosphate 21Cyclophosphamide 20Peripheral Blood Stem Cell Transplantation 19Busulfan 16Tacrolimus 14Whole-Body Irradiation 12Methotrexate 12Mycophenolic Acid 11Cyclosporine 11Antilymphocyte Serum 10fludarabine 6Filgrastim 6peginterferon alfa-2a 5ruxolitinib 4Radiotherapy 4Methylprednisolone 4Melphalan 4Flow Cytometry 4Etoposide 4Decitabine 4Aspirin 4Stem Cell Transplantation 3Injections 3Cytogenetic Analysis 3Cytarabine 3Biopsy 3Azacitidine 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3merphos 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thrombocythemia, Essential × Surveys and Questionnaires × Clear all
NCT02410551 2018-10-30

Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled 5 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡